Prospective surveillance for invasive Staphylococcus aureus and group A Streptococcus infections in a setting with high community burden of scabies and impetigo

被引:4
作者
Thean, Li Jun [1 ,2 ]
Jenney, Adam [3 ]
Engelman, Daniel [1 ,2 ,4 ]
Romani, Lucia [5 ]
Wand, Handan [5 ]
Mani, Jyotishna [1 ]
Paka, Jessica [1 ]
Cua, Tuliana [1 ]
Taole, Sera [1 ]
Soqo, Vika [6 ]
Sahukhan, Aalisha [6 ]
Kama, Mike [6 ]
Tuicakau, Meciusela [6 ]
Kado, Joseph [6 ,7 ]
Carvalho, Natalie [8 ]
Whitfeld, Margot [9 ,10 ]
Kaldor, John [5 ]
Steer, Andrew C. [1 ,2 ,4 ]
机构
[1] Murdoch Childrens Res Inst, Trop Dis Grp, Parkville, Vic, Australia
[2] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia
[3] Fiji Natl Univ, Coll Med Nursing & Hlth Sci, Suva, Fiji
[4] Royal Childrens Hosp, Melbourne Childrens Global Hlth, Melbourne Childrens Campus, Parkville, Vic, Australia
[5] Univ New South Wales, Kirby Inst, Kensington, NSW, Australia
[6] Minist Hlth & Med Serv, Suva, Fiji
[7] Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Nedlands, WA, Australia
[8] Univ Melbourne, Sch Populat & Global Hlth, Carlton, Vic, Australia
[9] St Vincents Hosp, Dept Dermatol, Darlinghurst, NSW, Australia
[10] Univ New South Wales, Sch Med, Kensington, NSW, Australia
基金
英国医学研究理事会;
关键词
Invasive infections; Staphylococcus aureus; Group A Streptococcus; Streptococcus pyogenes; Skin and soft tissue infection; UNITED-STATES; DISEASE; EPIDEMIOLOGY; POPULATION; PYOGENES; CHILDREN;
D O I
10.1016/j.ijid.2021.05.041
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Invasive Staphylococcus aureus (iSA) and group A Streptococcus (iGAS) impose significant health burdens globally. Both bacteria commonly cause skin and soft tissue infections (SSTIs), which can result in invasive disease. Understanding of the incidence of iSA and iGAS remains limited in settings with a high SSTI burden. Methods: Prospective surveillance for admissions with iSA or iGAS was conducted at the referral hospital in Fiji's Northern Division over 48 weeks between July 2018 and June 2019. Results: There were 55 admissions for iSA and 15 admissions for iGAS (incidence 45.2 and 12.3 per 100,000 person-years, respectively). The highest incidence was found in patients aged >= 65 years (59.6 per 100,000 person-years for iSA and iGAS). The incidence of iSA was higher in indigenous Fijians (iTaukei) (71.1 per 100,000 person-years) compared with other ethnicities (incidence rate ratio 9.7, 95% confidence interval 3.5-36.9). SSTIs were found in the majority of cases of iSA (75%) and iGAS (53.3%). Thirteen of the 14 iGAS strains isolated belonged to emm cluster D (n = 5) or E (n = 8). The case fatality rate was high for both iSA (10.9%) and iGAS (33.3%). Conclusions: The incidence of iSA and iGAS in Fiji is very high. SSTIs are common clinical foci for both iSA and iGAS. Both iSA and iGAS carry a substantial risk of death. Improved control strategies are needed to reduce the burden of iSA and iGAS in Fiji. (C) 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:333 / 339
页数:7
相关论文
共 32 条
  • [11] Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
    Harris, Paul A.
    Taylor, Robert
    Thielke, Robert
    Payne, Jonathon
    Gonzalez, Nathaniel
    Conde, Jose G.
    [J]. JOURNAL OF BIOMEDICAL INFORMATICS, 2009, 42 (02) : 377 - 381
  • [12] The clinical and molecular epidemiology of Staphylococcus aureus infections in Fiji
    Jenney, Adam
    Holt, Deborah
    Ritika, Roselyn
    Southwell, Paul
    Pravin, Shalini
    Buadromo, Eka
    Carapetis, Jonathan
    Tong, Steven
    Steer, Andrew
    [J]. BMC INFECTIOUS DISEASES, 2014, 14
  • [13] The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study
    Laupland, K. B.
    Lyytikainen, O.
    Sogaard, M.
    Kennedy, K. J.
    Knudsen, J. D.
    Ostergaard, C.
    Galbraith, J. C.
    Valiquette, L.
    Jacobsson, G.
    Collignon, P.
    Schonheyder, H. C.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (05) : 465 - 471
  • [14] Clinical and Microbial Characteristics of Invasive Streptococcus pyogenes Disease in New Caledonia, a Region in Oceania with a High Incidence of Acute Rheumatic Fever
    Le Hello, S.
    Doloy, A.
    Baumann, F.
    Roques, N.
    Coudene, P.
    Rouchon, B.
    Lacassin, F.
    Bouvet, A.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (02) : 526 - 530
  • [15] Magree HC, 2005, B WORLD HEALTH ORGAN, V83, P427
  • [16] Prevalence of Scabies and Impetigo 3 Years After Mass Drug Administration With Ivermectin and Azithromycin
    Marks, Michael
    Romani, Lucia
    Sokana, Oliver
    Neko, Lazarus
    Harrington, Relmah
    Nasi, Titus
    Wand, Handan
    Whitfeld, Margot J.
    Engelman, Daniel
    Solomon, Anthony W.
    Kaldor, John M.
    Steer, Andrew C.
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 70 (08) : 1591 - 1595
  • [17] Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012
    Nelson, George E.
    Pondo, Tracy
    Toews, Karrie-Ann
    Farley, Monica M.
    Lindegren, Mary Lou
    Lynfield, Ruth
    Aragon, Deborah
    Zansky, Shelley M.
    Watt, James P.
    Cieslak, Paul R.
    Angeles, Kathy
    Harrison, Lee H.
    Petit, Susan
    Beall, Bernard
    Van Beneden, Chris A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2016, 63 (04) : 478 - 486
  • [18] Norton R, 2004, INDIAN J MED RES, V119, P148
  • [19] The epidemiology of invasive group a streptococcal infection and potential vaccine implications: United States, 2000-2004
    O'Loughlin, Rosalyn E.
    Roberson, Angela
    Cieslak, Paul R.
    Lynfield, Ruth
    Gershman, Ken
    Craig, Allen
    Albanese, Bernadette A.
    Farley, Monica M.
    Barrett, Nancy L.
    Spina, Nancy L.
    Beall, Bernard
    Harrison, Lee H.
    Reingold, Arthur
    Van Beneden, Chris
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (07) : 853 - 862
  • [20] Invasive group A Streptococcus disease in Australian children: 2016 to 2018-a descriptive cohort study
    Oliver, Jane
    Thielemans, Elise
    McMinn, Alissa
    Baker, Ciara
    Britton, Philip N.
    Clark, Julia E.
    Marshall, Helen S.
    Blyth, Christopher C.
    Francis, Joshua
    Buttery, Jim
    Steer, Andrew C.
    Crawford, Nigel W.
    Booy, R.
    Connell, J.
    Dale, R.
    Deverell, M.
    Dinsmore, N.
    Dougherty, S.
    Finucane, C.
    Gibson, M.
    Gold, M.
    Heath, C.
    Hickie, L.
    Hutchinson, T.
    Jones, C.
    Jones, J.
    Kent, J.
    Knight, H.
    Kynaston, A.
    Lee, D.
    Lewis, G.
    Low, S.
    Maclean, N.
    Macartney, K.
    McDonald, F.
    McLaren, N.
    Mcrae, J.
    Murphy, J.
    Meredith, K.
    Nissen, M.
    Orr, C.
    Orr, K.
    Phillips, N.
    Pym, M.
    Quinn, J.
    Richmond, P.
    Rhind, L.
    Roberts, A.
    Robins, C.
    Rost, L.
    [J]. BMC PUBLIC HEALTH, 2019, 19 (01)